About
Technology
Issues
FAQ
Title
Abstract
Text
Figure Captions
Table Cells
Section Titles
Keywords
Subjects
Authors
From
2023
2022
2021
2020
2019
2018
2017
2016
2015
2014
2013
2012
2011
2010
2009
2008
2007
2006
2005
2004
2003
2002
2001
2000
1995
1990
1985
1980
1975
1970
1960
1950
1940
1930
1920
1910
1900
1850
1800
1700
1600
To
2023
2022
2021
2020
2019
2018
2017
2016
2015
2014
2013
2012
2011
2010
2009
2008
2007
2006
2005
2004
2003
2002
2001
2000
1995
1990
1985
1980
1975
1970
1960
1950
1940
1930
1920
1910
1900
1850
1800
1700
1600
All Types
Articles
Communications
Reviews
Discussions
Case Reports
Chapters
Books
News
Editorials
Order By
Order By Year ASC
Order By Year DESC
Order By Citations ASC
Order By Citations DESC
Go
Scientometrics
Impact Factor
Discipline Ranks
H-Index
G-Index
Articles
Citations
Article Citations
Citation Distribution
Search This Journal
Overviews
Top Institutions
Top Schools
Top Authors
Prolific Authors
Top Articles
exaly
›
Journals
›
Quarterly Journal of Nuclear Medicine and Molecular Imaging
›
Top Articles
Quarterly Journal of Nuclear Medicine and Molecular Imaging
Radiology
1.4
(top 11%)
Impact Factor
1.6
(top 11%)
extended IF
40
(top 10%)
H-Index
196
authors
810
papers
9.7K
citations
204
citing journals
704
citing authors
Most Cited Articles of Quarterly Journal of Nuclear Medicine and Molecular Imaging
Title
Year
Citations
Radiolabeled DOTATOC in patients with advanced paraganglioma and pheochromocytoma
2008
91
Bifunctional chelates for metal nuclides
2008
88
Need, feasibility and convenience of dosimetric treatment planning in liver selective internal radiation therapy with (90)Y microspheres: the experience of the National Tumor Institute of Milan
2011
88
Prostate-specific membrane antigen as a target for cancer imaging and therapy
2015
84
Bone mass loss and vitamin D metabolism impairment in HIV patients receiving highly active antiretroviral therapy
2004
79
Biodistribution of the Ga-68 labeled somatostatin analogue DOTA-NOC in patients with neuroendocrine tumors: characterization of uptake in normal organs and tumor lesions
2010
79
New PET radiopharmaceuticals beyond FDG for brain tumor imaging
2012
79
Labeled leukocyte imaging: current status and future directions
2009
78
Biological subtypes of breast cancer: current concepts and implications for recurrence patterns
2013
77
Dosimetry for treatment with radiolabelled somatostatin analogues. A review
2010
73
Fluorocholine (18F) and sodium fluoride (18F) PET/CT in the detection of prostate cancer: prospective comparison of diagnostic performance determined by masked reading
2011
71
A review of human anti-globulin antibody (HAGA, HAMA, HACA, HAHA) responses to monoclonal antibodies. Not four letter words
2004
69
Imaging reporter genes for cell tracking with PET and SPECT
2005
65
Imaging of infectious diseases using [18F] fluorodeoxyglucose PET
2008
62
Lung metastases from differentiated thyroid carcinoma. A 40 years' experience
2004
58
Detection and treatment of pheochromocytomas and paragangliomas: current standing of MIBG scintigraphy and future role of PET imaging
2008
57
Assessing tumor hypoxia by positron emission tomography with Cu-ATSM
2009
53
Octreo-SPECT/CT imaging for accurate detection and localization of suspected neuroendocrine tumors
2008
53
Radioimmunotherapy with alpha-particle emitting radionuclides
2004
50
In vivo visualization of 111In labeled CD133+ peripheral blood stem cells after intracoronary administration in patients with chronic ischemic heart disease
2007
49
The nonpeptidyl caspase binding radioligand (S)-1-(4-(2-[18F]Fluoroethoxy)-benzyl)-5-[1-(2-methoxymethylpyrrolidinyl)sulfonyl]isatin ([18F]CbR) as potential positron emission tomography-compatible apoptosis imaging agent
2007
49
Bone marrow disease detection with FDG-PET/CT and bone marrow biopsy during the staging of malignant lymphoma: results from a large multicentre study
2011
49
The value of FDG-PET in the follow-up of differentiated thyroid cancer: a review of the literature
2006
47
Advances in cancer therapy with radiolabeled monoclonal antibodies
2006
47
MIBG for diagnosis and therapy of medullary thyroid carcinoma: is there still a role?
2008
47
0
1
2
next
How are inpact factors calculated?
The impact factor (IF) is calculated by counting citations from peer-reviewed journals only.
extended IF
also counts citations from books and conference papers. However, no patent, abstract, working papers, online documents, etc., are covered.
site/software ©
exaly
; All materials licenced under
CC by-SA
.